From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis

Ítems similars

• Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
  Publicat: (2020)
• Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
  per: Wang, Yiting, et al.
  Publicat: (2020)
• The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”
  per: Bersanelli, Melissa, et al.
  Publicat: (2021)
• Systemic antitumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors
  per: O’Shaughnessy, Matthew J., et al.
  Publicat: (2017)
• Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis
  per: Tabana, Yasser, et al.
  Publicat: (2021)